Literature DB >> 28150539

Current best practice in rehabilitation in interstitial lung disease.

Atsuhito Nakazawa1, Narelle S Cox2, Anne E Holland3.   

Abstract

Interstitial lung disease (ILD) is a group of chronic respiratory diseases characterized by dyspnoea on exertion and decline in health-related quality of life (HRQL). People with ILD experience significant exercise limitation with contributors that include ventilatory limitation, impaired gas exchange, decreased cardiac function and skeletal muscle dysfunction. Pulmonary rehabilitation (PR) is well established in patients with chronic obstructive pulmonary disease (COPD) as a means to overcome exercise limitation and improve activity-related dyspnoea. There is increasing evidence for similar effects of PR in people with ILD. This review discusses the evidence for PR in ILD, outlines the essential components of PR in this population, and highlights special considerations for exercise training in people with ILD. Possible future directions for PR research in people with ILD are explored.

Entities:  

Keywords:  education; exercise limitation; exercise training; interstitial lung disease; pulmonary rehabilitation

Mesh:

Year:  2016        PMID: 28150539      PMCID: PMC5933636          DOI: 10.1177/1753465816676048

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  66 in total

Review 1.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

2.  6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Jonathan A Leff; Paul W Noble; Steven A Sahn; Dominique Valeyre; Derek Weycker; Talmadge E King
Journal:  Eur Respir J       Date:  2013-12-05       Impact factor: 16.671

3.  Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.

Authors:  Mariana S Araujo; Bruno G Baldi; Carolina S G Freitas; André L P Albuquerque; Cibele C B Marques da Silva; Ronaldo A Kairalla; Celso R F Carvalho; Carlos R R Carvalho
Journal:  Eur Respir J       Date:  2016-02-25       Impact factor: 16.671

4.  Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial.

Authors:  Christophe M Pison; Noël J Cano; Cécile Chérion; Fabrice Caron; Isabelle Court-Fortune; Marie-Thérèse Antonini; Jésus Gonzalez-Bermejo; Lahouari Meziane; Luis Carlos Molano; Jean-Paul Janssens; Frédéric Costes; Bernard Wuyam; Thomas Similowski; Boris Melloni; Maurice Hayot; Julie Augustin; Catherine Tardif; Hervé Lejeune; Hubert Roth; Claude Pichard
Journal:  Thorax       Date:  2011-06-23       Impact factor: 9.139

5.  Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease.

Authors:  Anne E Holland; Julio F Fiore; Emily C Bell; Nicole Goh; Glen Westall; Karen Symons; Leona Dowman; Ian Glaspole
Journal:  Respirology       Date:  2014-08-12       Impact factor: 6.424

6.  American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise.

Authors:  Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain
Journal:  Med Sci Sports Exerc       Date:  2011-07       Impact factor: 5.411

7.  Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis.

Authors:  Shinichi Arizono; Hiroyuki Taniguchi; Koji Sakamoto; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Tomoya Ogawa; Fumiko Watanabe; Osamu Nishiyama; Koichi Nishimura; Ryo Kozu; Kazuyuki Tabira
Journal:  Respir Care       Date:  2013-12-10       Impact factor: 2.258

8.  Development of a shuttle walking test of disability in patients with chronic airways obstruction.

Authors:  S J Singh; M D Morgan; S Scott; D Walters; A E Hardman
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

9.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

10.  An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial.

Authors:  Neil J Greening; Johanna E A Williams; Syed F Hussain; Theresa C Harvey-Dunstan; M John Bankart; Emma J Chaplin; Emma E Vincent; Rudo Chimera; Mike D Morgan; Sally J Singh; Michael C Steiner
Journal:  BMJ       Date:  2014-07-08
View more
  18 in total

1.  Effect of pulmonary rehabilitation on functional exercise capacity and hypoxemia in patients with interstitial lung diseases: a retrospective study.

Authors:  Salvatore Fuschillo; Alberto De Felice; Andrea Elia; Michele Martucci; Carlo Gaudiosi; Dino Vitali; Mauro Maniscalco
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: A randomized trial.

Authors:  Hatem Essam; Nashwa Hassan Abdel Wahab; Gihan Younis; Enas El-Sayed; Hanaa Shafiek
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Impact of supervised exercise training on pulmonary function parameters, exercise capacity and Irisin Biomarker in Interstitial lung disease patients.

Authors:  Rahma Mohammad Alyami; Abdulrahman Mohammed Alhowikan; Abdullah Rashed Alharbi; Ghada Al-Nafisah
Journal:  Pak J Med Sci       Date:  2020 Jul-Aug       Impact factor: 1.088

Review 4.  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

Authors:  Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-07-01       Impact factor: 4.991

Review 5.  Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions.

Authors:  Paola Faverio; Marialuisa Bocchino; Antonella Caminati; Alessia Fumagalli; Monica Gasbarra; Paola Iovino; Alessandra Petruzzi; Luca Scalfi; Alfredo Sebastiani; Anna Agnese Stanziola; Alessandro Sanduzzi
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 6.  Effects of high intensity interval training on exercise capacity in people with chronic pulmonary conditions: a narrative review.

Authors:  Abbey Sawyer; Vinicius Cavalheri; Kylie Hill
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-03-30

7.  A comparison trial of eight weeks versus twelve weeks of exercise program in interstitial lung diseases.

Authors:  Ilknur Naz; Hulya Sahin; Fatma Demirci Uçsular; Enver Yalnız
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

8.  Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study.

Authors:  Owen Tomlinson; Anna Duckworth; Laura Markham; Rebecca Wollerton; Bridget Knight; Alexander Spiers; Michael Gibbons; Craig Williams; Chris Scotton
Journal:  BMJ Open Respir Res       Date:  2021-04

9.  Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Adelle S Jee; Robert Sheehy; Peter Hopkins; Tamera J Corte; Christopher Grainge; Lauren K Troy; Karen Symons; Lissa M Spencer; Paul N Reynolds; Sally Chapman; Sally de Boer; Taryn Reddy; Anne E Holland; Daniel C Chambers; Ian N Glaspole; Helen E Jo; Jane F Bleasel; Jeremy P Wrobel; Leona Dowman; Matthew J S Parker; Margaret L Wilsher; Nicole S L Goh; Yuben Moodley; Gregory J Keir
Journal:  Respirology       Date:  2020-11-24       Impact factor: 6.424

10.  Using step counters to promote physical activity and exercise capacity in patients with chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Shanhu Qiu; Xue Cai; Xuyi Wang; Can He; Martina Zügel; Jürgen Michael Steinacker; Uwe Schumann
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.